PMID: 7535891Apr 14, 1995Paper

Progress toward global poliomyelitis eradication, 1985-1994

MMWR. Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention (CDC)

Abstract

In 1985, the Pan American Health Organization (PAHO) established as a goal the elimination of poliomyelitis from the Western Hemisphere by 1990; the last confirmed case of paralytic polio caused by wild poliovirus occurred in 1991 in Peru. In 1988, the World Health Assembly established the objective of global polio eradication by the year 2000. Substantial progress toward this goal has resulted from the use of four strategies recommended by the World Health Organization (WHO): 1) maintenance of high vaccination coverage levels among children with at least three doses of oral poliovirus vaccine (OPV); 2) development of sensitive systems of epidemiologic and laboratory surveillance, including use of the standard WHO case definition; 3) administration of supplementary doses of OPV to all young children (usually those aged < 5 years) during National Immunization Days (NIDs) to rapidly interrupt poliovirus transmission; and 4) "mopping-up" vaccination campaigns--localized campaigns targeted at high-risk areas where wild poliovirus transmission is most likely to persist at low levels (3). This report summarizes progress toward global polio eradication from 1985 through 1994 based on data submitted to WHO as of March 20, 1995.

Citations

May 11, 1996·BMJ : British Medical Journal·J Chander, S Subrahmanyan
Apr 1, 1996·Current Problems in Pediatrics·P D ReumanE M Ayoub

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

MMWR. Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention (CDC)
MMWR. Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention (CDC)
MMWR. Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention (CDC)
MMWR. Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention (CDC)
MMWR. Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention (CDC)
© 2021 Meta ULC. All rights reserved